3rd Department of General Surgery, Jagiellonian University School of Medicine, Pradnicka 35-37, 31-202, Krakow, Poland.
World J Surg. 2010 Jul;34(7):1604-8. doi: 10.1007/s00268-010-0482-8.
Rectum-sparing transanal endoscopic microsurgery (TEM) is a well-established treatment for T1 carcinomas of the rectum. However, it is associated with an increased rate of local recurrence compared with extended resection. In most cases, this failure is linked to the presence of clinically nondetectable metastases in the regional lymph nodes. Endoscopic posterior mesorectal resection (EPMR) makes it possible to remove the relevant lymphatic drainage of the lower third of the rectum in the minimally invasive way, which can help with adequate tumor staging. The study evaluated the influence of combined TEM and EPMR treatment on the anorectal functions of this group of patients.
Six consecutive patients (3 women and 3 men; mean age, 71.3 years) with T1 cancer of the rectum were operated on using TEM in combination with EPMR as a two-stage procedure between 2007 and 2009.
After a median follow-up of 19 (range, 8-30) months, none of our patients complained of symptoms of incontinence during the postoperative period apart from one woman with gas incontinence, who was diagnosed preoperatively. There was no statistically significant difference in BAP, SAP, HPZL, or in fecal continence control assessed using the Fecal Incontinence Severity Index before and 1, 3, and 6 months after the procedure. We observed one case of intraoperative complication (perforation) and one case of minor postoperative complication (hematoma formation). There was no evidence of locoregional recurrence.
EPMR in combination with TEM seems to be safe, feasible, and with no impact on the basic anorectal functions.
经肛门内镜微创手术(TEM)是一种成熟的治疗直肠 T1 癌的方法。然而,与扩大切除相比,它与局部复发率增加有关。在大多数情况下,这种失败与区域淋巴结中临床无法检测到的转移有关。内镜后直肠系膜切除术(EPMR)可微创切除直肠下三分之一的相关淋巴引流,有助于进行充分的肿瘤分期。本研究评估了 TEM 和 EPMR 联合治疗对该组患者肛门直肠功能的影响。
2007 年至 2009 年间,我们对 6 例连续的直肠 T1 癌患者(3 名女性和 3 名男性;平均年龄 71.3 岁)进行了 TEM 联合 EPMR 的两阶段手术。
中位随访 19 个月(范围 8-30 个月),除了一名术前有气体失禁的女性外,我们所有患者在术后期间均未出现失禁症状。在手术前后,BAP、SAP、HPZL 或使用粪便失禁严重程度指数评估的粪便控制均无统计学差异。我们观察到 1 例术中并发症(穿孔)和 1 例轻微术后并发症(血肿形成)。无局部复发证据。
EPMR 联合 TEM 似乎是安全、可行的,并且对基本的肛门直肠功能没有影响。